Mineralys Therapeutics, Inc. (MLYS) Ownership

$38.06

south_east
-$2.4 (-5.93%)
Day's range
$38.04
Day's range
$40.91

Mineralys Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
CATALYS PACIFIC, LLC 11/14/2025 8.90 M $337.63 M   0.00% 13.60%
RA CAPITAL MANAGEMENT, L.P. 11/14/2025 7.32 M $277.72 M   19.14% 11.19%
SAMSARA BIOCAPITAL, LLC 11/14/2025 6.26 M $237.50 M   10.37% 9.57%
BLACKROCK, INC. 11/12/2025 3.67 M $139.23 M   18.52% 5.61%
VANGUARD GROUP INC 11/07/2025 3.02 M $114.48 M   29.77% 4.61%
CALIGAN PARTNERS LP 11/14/2025 2.77 M $105.14 M   37.44% 4.24%
CAPITAL INTERNATIONAL INVESTORS 11/13/2025 2.39 M $90.76 M   -17.44% 3.66%
SUVRETTA CAPITAL MANAGEMENT, LLC 11/14/2025 2.13 M $80.85 M   22.22% 3.26%
SR ONE CAPITAL MANAGEMENT, LP 11/12/2025 2.11 M $80.16 M   -32.42% 3.23%
FMR LLC 11/13/2025 2.07 M $78.54 M   579.35% 3.16%
CITADEL ADVISORS LLC 11/14/2025 2.07 M $78.39 M   14,273.71% 3.16%
FRANKLIN RESOURCES INC 11/13/2025 1.81 M $68.63 M   0.34% 2.77%
POINT72 ASSET MANAGEMENT, L.P. 11/14/2025 1.80 M $68.24 M   100.00% 2.75%
LAURION CAPITAL MANAGEMENT LP 11/17/2025 1.72 M $65.24 M   -2.39% 2.63%
FARALLON CAPITAL MANAGEMENT LLC 11/14/2025 1.67 M $63.44 M   100.00% 2.56%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 11/14/2025 1.50 M $56.88 M   -44.44% 2.29%
ORBIMED ADVISORS LLC 11/14/2025 1.47 M $55.72 M   93.27% 2.25%
MORGAN STANLEY 11/14/2025 1.38 M $52.22 M   134.25% 2.10%
STATE STREET CORP 11/14/2025 1.30 M $49.41 M   -9.74% 1.99%
HOLOCENE ADVISORS, LP 11/14/2025 1.21 M $45.71 M   100.00% 1.84%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 1.12 M $42.61 M   17.69% 1.72%
POLAR CAPITAL HOLDINGS PLC 11/14/2025 1.06 M $40.15 M   100.00% 1.62%
BOOTHBAY FUND MANAGEMENT, LLC 11/14/2025 942.63 K $35.74 M   15.39% 1.44%
PICTET ASSET MANAGEMENT HOLDING SA 11/18/2025 929.17 K $35.23 M   -26.72% 1.42%
ALLIANCEBERNSTEIN L.P. 11/14/2025 882.42 K $33.46 M   3,160.11% 1.35%
AMERICAN CENTURY COMPANIES INC 11/12/2025 879.68 K $33.36 M   5.38% 1.34%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2025 783.45 K $29.71 M   578.61% 1.20%
BANK OF AMERICA CORP /DE/ 11/14/2025 768.27 K $29.13 M   191.72% 1.17%
AFFINITY ASSET ADVISORS, LLC 11/13/2025 750.00 K $28.44 M   -16.67% 1.15%
GOLDMAN SACHS GROUP INC 11/14/2025 711.66 K $26.99 M   13.54% 1.09%
BARCLAYS PLC 11/12/2025 653.83 K $24.79 M   354.41% 1.00%
BNP PARIBAS ARBITRAGE, SNC 11/13/2025 626.15 K $23.74 M   15,142.16% 0.96%
D. E. SHAW & CO., INC. 11/14/2025 610.92 K $23.17 M   6.39% 0.93%
CANDRIAM S.C.A. 11/06/2025 567.78 K $21.53 M   -31.11% 0.87%
PALE FIRE CAPITAL SE 11/13/2025 532.41 K $20.19 M   19.21% 0.81%
ARMISTICE CAPITAL, LLC 11/17/2025 507.65 K $19.25 M   185.20% 0.78%
PARKMAN HEALTHCARE PARTNERS LLC 11/14/2025 455.52 K $17.27 M   -1.74% 0.70%
NEARWATER CAPITAL MARKETS, LTD 11/13/2025 450.00 K $17.06 M   100.00% 0.69%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 409.19 K $15.52 M   26.21% 0.63%
ROCK SPRINGS CAPITAL MANAGEMENT LP 11/14/2025 408.31 K $15.48 M   25.82% 0.62%
MILLENNIUM MANAGEMENT LLC 11/14/2025 404.59 K $15.34 M   66.11% 0.62%
NORTHERN TRUST CORP 11/14/2025 390.81 K $14.82 M   15.27% 0.60%
JENNISON ASSOCIATES LLC 10/30/2025 376.35 K $14.27 M   -69.53% 0.58%
22NW, LP 11/14/2025 358.33 K $13.59 M   -36.02% 0.55%
CAPTION MANAGEMENT, LLC 11/14/2025 320.00 K $12.13 M   540.00% 0.49%
SWEDBANK AB 10/15/2025 299.30 K $11.35 M   -22.02% 0.46%
FINDELL CAPITAL MANAGEMENT LLC 11/14/2025 250.00 K $9.48 M   100.00% 0.38%
SPHERA FUNDS MANAGEMENT LTD. 11/14/2025 219.91 K $8.34 M   -54.28% 0.34%
SIMPLIFY ASSET MANAGEMENT INC. 10/20/2025 218.73 K $8.29 M   100.00% 0.33%
HIGHVISTA STRATEGIES LLC 11/14/2025 209.83 K $7.96 M   39.76% 0.32%

Mineralys Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 214 institutional investors and hedge funds held shares of Mineralys Therapeutics, Inc.. The most heavily invested institutionals were:

Catalys Pacific, LLC: 8.9 M

RA CAPITAL MANAGEMENT, L.P.: 7.32 M

Samsara BioCapital, LLC: 6.26 M

BlackRock, Inc.: 3.67 M

VANGUARD GROUP INC: 3.02 M

Caligan Partners LP: 2.77 M

121.41% of Mineralys Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 82.15 M shares in the last 24 months. This purchase volume represents approximately $3.13 B in transactions.